Mechanisms of resistance to aromatase inhibitors
- 31 May 2005
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 95 (1-5) , 167-172
- https://doi.org/10.1016/j.jsbmb.2005.04.022
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal WomenJNCI Journal of the National Cancer Institute, 2004
- Aromatase Inhibitors in Breast CancerNew England Journal of Medicine, 2003
- Human Epidermal Growth Factor Receptor—2 and Hormonal Therapies: Clinical ImplicationsClinical Breast Cancer, 2003
- Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivationThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter studyAnnals of Oncology, 2001
- Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialJournal of Clinical Oncology, 2001
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Aromatase activity and CYP19 gene expression in breast cancersThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cellsJournal of Clinical Endocrinology & Metabolism, 1995
- Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patientsThe Journal of Steroid Biochemistry and Molecular Biology, 1992